Brief: Kura Oncology Receives Second $30 Million Development Milestone Payment In Aml Menin Inhibitor Program With Kyowa Kirin
03/11/2025 23:20
Nov 4 (Reuters) - Kura Oncology Inc KURA.O: KURA ONCOLOGY RECEIVES SECOND $30 MILLION DEVELOPMENT MILESTONE PAYMENT IN AML MENIN INHIBITOR PROGRAM WITH KYOWA KIRIN KURA ONCOLOGY INC - EXPECTS UP TO $315 MILLION IN ADDITIONAL MILESTONES Source text: ID:nGNX78qZTn Further company coverage: KURA.O ((Reuters.Briefs@thomsonreuters.com;))